ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in ProQR Therapeutics N.V. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- −5 vs. Q2 2023
- Shares held
- 18.7M
- −2.42M (−11.4%) vs. Q2 2023
- Total value
- $24.3M
- −$9.91M (−28.9%) vs. Q2 2023
- New holders
- 4
- 8 more added
- Sold out
- 9
- 10 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRQR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $113.0M |
| Q1 2026 | 69 | $56.8M |
| Q4 2025 | 65 | $75.1M |
| Q3 2025 | 64 | $80.0M |
| Q2 2025 | 62 | $82.4M |
| Q1 2025 | 65 | $54.9M |
| Q4 2024 | 77 | $117.7M |
| Q3 2024 | 47 | $31.7M |
| Q2 2024 | 48 | $28.6M |
| Q1 2024 | 49 | $39.8M |
| Q4 2023 | 47 | $37.0M |
| Q3 2023 | 46 | $24.3M |
| Q2 2023 | 51 | $34.2M |
| Q1 2023 | 55 | $47.5M |
| Q4 2022 | 46 | $60.0M |
| Q3 2022 | 47 | $15.9M |
| Q2 2022 | 51 | $17.2M |
| Q1 2022 | 58 | $28.7M |
| Q4 2021 | 74 | $364.8M |
| Q3 2021 | 67 | $333.4M |
| Q2 2021 | 63 | $259.4M |
| Q1 2021 | 64 | $286.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding ProQR Therapeutics N.V.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 33 | $43 | 0.00% | +33 | New |
| PFS Partners, LLC | 1,000 | $1.30K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 1,000 | $1.30K | 0.00% | +1,000 | New |
| Flaharty Asset Management, LLC | 2,000 | $2.60K | 0.00% | +2,000 | New |
| Cutler Group LP | 4,600 | $5.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 3,945 | $5.13K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 6,214 | $7.00K | 0.00% | +302+5.1% | Added |
| BNP Paribas Arbitrage, SA | 6,701 | $8.71K | 0.00% | −3,226−32.5% | Reduced |
| Group One Trading, L.P. | 9,766 | $12.7K | 0.00% | +5,874+150.9% | Added |
| Truist Financial Corp | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Vontobel Holding Ltd. | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Csenge Advisory Group | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10,044 | $13.1K | 0.00% | +5,363+114.6% | Added |
| Wells Fargo & Company | 10,996 | $14.3K | 0.00% | 00.0% | Unchanged |
| Atom Investors LP | 13,107 | $17.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 14,689 | $19.0K | 0.00% | +8,159+124.9% | Added |
| Northern Trust Corp | 17,420 | $22.6K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 18,334 | $23.8K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 19,461 | $25.3K | 0.00% | −1,665−7.9% | Reduced |
| Resources Investment Advisors, LLC. | 19,525 | $25.4K | 0.00% | +4,225+27.6% | Added |
| Invesco Ltd. | 20,822 | $27.1K | 0.00% | +1,700+8.9% | Added |
| JustInvest LLC | 21,429 | $27.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 36,293 | $47.2K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 40,610 | $52.8K | 0.00% | +40,610 | New |
| Marshall Wace, LLP | 57,717 | $75.0K | 0.00% | −251,742−81.3% | Reduced |
| Gsa Capital Partners LLP | 74,084 | $96.0K | 0.01% | +30,248+69.0% | Added |
| Boothbay Fund Management, LLC | 95,745 | $124.5K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 108,338 | $140.8K | 0.00% | −46,148−29.9% | Reduced |
| Squarepoint Ops LLC | 132,378 | $172.1K | 0.00% | −1,764−1.3% | Reduced |
| JPMorgan Chase & Co | 147,505 | $191.8K | 0.00% | −32,892−18.2% | Reduced |
| Franklin Street Advisors Inc | 150,000 | $195.0K | 0.02% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 180,744 | $235.0K | 0.00% | −307,100−63.0% | Reduced |
| UBS Oconnor LLC | 189,328 | $246.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 228,200 | $296.7K | 0.00% | −233,000−50.5% | Reduced |
| Morgan Stanley | 342,958 | $445.8K | 0.00% | −152,558−30.8% | Reduced |
| Monaco Asset Management SAM | 377,517 | $490.8K | 0.25% | +140,000+58.9% | Added |
| Millennium Management LLC | 420,045 | $546.1K | 0.00% | −191,616−31.3% | Reduced |
| Ikarian Capital, LLC | 472,625 | $614.4K | 0.23% | 00.0% | Unchanged |
| Macquarie Group Ltd | 620,000 | $806.0K | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 940,582 | $1.22M | 0.38% | 00.0% | Unchanged |
| M28 Capital Management LP | 1,910,600 | $2.48M | 2.85% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,980,016 | $3.87M | 0.13% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,625,467 | $4.71M | 0.01% | 00.0% | Unchanged |
| Privium Fund Management B.V. | 5,344,446 | $6.95M | 2.07% | 00.0% | Unchanged |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −653,000−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −385,208−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −200,499−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −116,792−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −23,160−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −21,494−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −20,550−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,405−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |